Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006.

Alessi-Severini S, Biscontri RG, Collins DM, Kozyrskyj A, Sareen J, Enns MW.

Psychiatr Serv. 2008 May;59(5):547-53. doi: 10.1176/appi.ps.59.5.547.

PMID:
18451015
[PubMed - indexed for MEDLINE]
2.

Clinical trial-based cost-effectiveness analyses of antipsychotic use.

Polsky D, Doshi JA, Bauer MS, Glick HA.

Am J Psychiatry. 2006 Dec;163(12):2047-56. Review.

PMID:
17151153
[PubMed - indexed for MEDLINE]
3.

[Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics].

Girona-Brumós L, Ribera-Montañá R, Juárez-Giménez JC, Pilar Lalueza-Broto M.

Gac Sanit. 2006 Mar;20 Suppl 1:143-53. Review. Spanish.

PMID:
16539977
[PubMed - indexed for MEDLINE]
Free Article
4.

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.

Sun SX, Liu GG, Christensen DB, Fu AZ.

Curr Med Res Opin. 2007 Oct;23(10):2305-12. Review.

PMID:
17697454
[PubMed - indexed for MEDLINE]
5.

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia.

Edwards NC, Pesa J, Meletiche DM, Engelhart L, Thompson AK, Sherr J, Dirani R.

Curr Med Res Opin. 2008 Dec;24(12):3341-55. doi: 10.1185/03007990802490512 . Review.

PMID:
18954497
[PubMed - indexed for MEDLINE]
6.

Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies.

Tunis SL, Johnstone BM, Kinon BJ, Barber BL, Browne RA.

Value Health. 2000 May-Jun;3(3):232-42. Review.

PMID:
16464187
[PubMed - indexed for MEDLINE]
7.

Antipsychotic therapy: a pharmacoeconomic perspective.

Rey JA.

Am J Health Syst Pharm. 2002 Nov 15;59(22 Suppl 8):S5-9. Review.

PMID:
12455293
[PubMed - indexed for MEDLINE]
8.

Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia.

Mauskopf J, Muroff M, Gibson PJ, Grainger DL.

Schizophr Bull. 2002;28(4):619-35. Review.

PMID:
12795495
[PubMed - indexed for MEDLINE]
Free Article
9.

Novel antipsychotics and patient care in state hospitals.

Buckley PF.

Ann Pharmacother. 1998 Sep;32(9):906-14. Review.

PMID:
9762379
[PubMed - indexed for MEDLINE]
10.

Health economic measures in schizophrenia research.

McCrone P.

Br J Psychiatry Suppl. 2007 Aug;50:s42-5. Review.

PMID:
18019043
[PubMed - indexed for MEDLINE]
11.

Different study criteria affect the prevalence of benzodiazepine use.

Zandstra SM, Furer JW, van de Lisdonk EH, van't HM, Bor JH, van Weel C, Zitman FG.

Soc Psychiatry Psychiatr Epidemiol. 2002 Mar;37(3):139-44. Review.

PMID:
11990011
[PubMed - indexed for MEDLINE]
12.

Real-world antipsychotic treatment practices.

Moore TA, Covell NH, Essock SM, Miller AL.

Psychiatr Clin North Am. 2007 Sep;30(3):401-16. Review.

PMID:
17720029
[PubMed - indexed for MEDLINE]
13.

Templates for analysis of individual-level prescription data.

Hallas J, Støvring H.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):260-5. Review.

PMID:
16611200
[PubMed - indexed for MEDLINE]
14.

[Pharmacoeconomic evaluations on antipsychotics in schizophrenia: a review of the Italian studies].

Cerzani M, Barbui C, Garattini L.

Epidemiol Psichiatr Soc. 2006 Apr-Jun;15(2):153-60. Review. Italian. No abstract available.

PMID:
16865937
[PubMed - indexed for MEDLINE]
15.

[Duration and principles of the prescription of neuroleptics in maintain therapy].

Maslovskiĭ SIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(12):81-5. Review. Russian. No abstract available.

PMID:
17274403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk